Institutional investors purchased a net $277.3 thousand shares of NEO during the quarter ended September 2015. This may signal that the smart money is gaining interest in this company as the 63.71% of shares outstanding that institutional investors hold is actually below the Medical/Nursing Services industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
EAM INVESTORS LLC Bought 368.9 Thousand shares of Neogenomics Inc
SUMMIT CREEK ADVISORS LLC Bought 275.6 Thousand shares of Neogenomics Inc
RUSSELL INVESTMENT MANAGEMENT CO... Bought 152.9 Thousand shares of Neogenomics Inc